Last reviewed · How we verify

IDP-121 Vehicle Lotion

Bausch Health Americas, Inc. · Phase 3 active Small molecule

IDP-121 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect.

IDP-121 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect. Used for Dermatological conditions (specific indication dependent on active ingredient formulated in vehicle).

At a glance

Generic nameIDP-121 Vehicle Lotion
SponsorBausch Health Americas, Inc.
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

IDP-121 Vehicle Lotion is a dermatological formulation platform developed by Bausch Health. As a vehicle lotion, it serves as the delivery system for active ingredients in topical treatment. The specific mechanism depends on the active pharmaceutical ingredient incorporated into this vehicle formulation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: